HI
TXMD icon

Handelsinvest Investeringsforvaltning’s TherapeuticsMD TXMD Stock Holding History

Handelsinvest Investeringsforvaltning’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-24,000
Closed -$1.45M – 126
2020
Q4 		$1.45M Buy
24,000
+6,000
+33% +$410K 0.22% 92
2020
Q3 		$1.41M Buy
+18,000
New +$1.43M 0.27% 88

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Handelsinvest Investeringsforvaltning's TXMD Position: Q1 2021 in Review

Handelsinvest Investeringsforvaltning sold out of TherapeuticsMD (TXMD) in Q1 2021, closing a stake of 24,000 shares — an estimated $1.45M sold.

Handelsinvest Investeringsforvaltning first reported a position in TXMD in Q3 2020 and held it in 2 quarters. The position peaked at $1.45M in Q4 2020. 160 funds tracked by Wall St. Rank hold TXMD as of Q1 2021.

  • Handelsinvest Investeringsforvaltning reported no remaining TherapeuticsMD position as of Q1 2021 after selling out during the quarter.
  • Handelsinvest Investeringsforvaltning sold 24,000 TherapeuticsMD shares in Q1 2021, an estimated $1.45M.
  • Handelsinvest Investeringsforvaltning first reported a position in TherapeuticsMD in Q3 2020 and held it in 2 quarters.
  • Handelsinvest Investeringsforvaltning's TherapeuticsMD position peaked at $1.45M in Q4 2020.
  • 160 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2021.

Based on Handelsinvest Investeringsforvaltning's 13F filing for Q1 2021, filed 20 Apr 2021.